AnPac Bio-Medical Science...

NASDAQ: ANPC · Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 9:59 PM

AnPac Bio-Medical Science Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
437K 6.39M 3.25M 1.97M 4.31M 4.42M 7.07M 2.19M
Cost of Revenue
470K 1.41M 954K 878K 165K 1.99M 2.67M 908K
Gross Profit
-33K 4.99M 2.29M 1.09M 4.14M 2.43M 4.41M 1.28M
Operating Income
-31.97M -22.07M -36.23M -14.54M -32.09M -27.7M -27.15M -25.17M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-32.46M -22.33M -35.95M -14.99M -32.2M -31.33M -28.46M -29.27M
Net Income
-32.31M -20.2M -33.91M -14.9M -31.14M -30.55M -28.01M -29.03M
Selling & General & Admin
30.32M 23.46M 15.93M 13.22M 25.84M 23.88M 29.29M 23.09M
Research & Development
1.61M 3.59M 1.92M 2.41M 4.34M 6.25M 2.26M 3.36M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
31.94M 27.05M 17.86M 15.63M 30.18M 30.13M 31.55M 26.45M
Interest Expense
79K 102K 99K 93K 117K 1.92M 1.6M 624K
Selling & Marketing Expenses
3.29M 3.51M 2.42M 2.93M 4.08M 6.52M 6.95M 3.86M
Cost & Expenses
32.41M 28.46M 18.81M 16.5M 30.34M 32.12M 34.22M 27.35M
Income Tax Expense
-144K -2.13M -2.04M -90K -1.07M -67K -22K -22K
Shares Outstanding (Basic)
1.91M 1.45M 865.08K 865.08K 597.9K 11.96M 597.9K 597.9K
Shares Outstanding (Diluted)
1.91M 1.45M 865.08K 865.08K 597.9K 11.96M 597.9K 597.9K
EPS (Basic)
-16.9 -13.95 -39.2 -17.22 -52.07 -2.55 -46.84 -48.55
EPS (Diluted)
-16.9 -13.95 -39.2 -17.22 -52.07 -2.55 -46.84 -48.55
EBITDA
-32.66M -21.66M -14.68M -14.9M -32.06M -28.7M -26.43M -28.43M
EBIT
-32.38M -22.22M -35.86M -14.9M -32.09M -29.41M -26.87M -28.64M
Depreciation & Amortization
-693K 408K 21.56M -363K 26K -1M 715K -3.26M